Dyslipidemia and the progression of renal disease in chronic renal failure patients
- 1 December 2005
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 68 (99), S87-S93
- https://doi.org/10.1111/j.1523-1755.2005.09916.x
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Statins Prevent Oxidized LDL-Induced Injury of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/AKT-Signaling PathwayJournal of the American Society of Nephrology, 2005
- Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)The American Journal of Cardiology, 2005
- Rosuvastatin-Induced Arrest in Progression of Renal DiseaseCardiology, 2004
- Predictors of New-Onset Kidney Disease in a Community-Based PopulationJAMA, 2004
- Effect of simvastatin on renal function in autosomal dominant polycystic kidney diseaseNephrology Dialysis Transplantation, 2001
- Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities StudyKidney International, 2000
- Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patientsNephrology Dialysis Transplantation, 1996
- Effects of Hypertension and Dyslipidemia on the Decline in Renal FunctionHypertension, 1995
- Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus.Japanese Journal of Medicine, 1990
- Lipids and Progressive GlomerulosclerosisAmerican Journal of Nephrology, 1988